ABVC BioPharma, Inc. (ABVC)
1.00
+0.02
(+2.04%)
USD |
NASDAQ |
Oct 09, 16:00
1.00
0.00 (0.00%)
Pre-Market: 20:00
ABVC BioPharma Total Return Level : 1.00 for Oct. 9, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.00 |
| October 08, 2026 | 0.98 |
| October 07, 2026 | 1.00 |
| October 06, 2026 | 0.97 |
| October 05, 2026 | 0.98 |
| October 02, 2026 | 1.01 |
| October 01, 2026 | 1.02 |
| September 30, 2026 | 1.06 |
| September 29, 2026 | 1.04 |
| September 28, 2026 | 1.05 |
| September 25, 2026 | 1.13 |
| September 24, 2026 | 1.09 |
| September 23, 2026 | 1.14 |
| September 22, 2026 | 1.16 |
| September 21, 2026 | 1.15 |
| September 18, 2026 | 1.16 |
| September 17, 2026 | 1.15 |
| September 16, 2026 | 1.08 |
| September 15, 2026 | 1.07 |
| September 14, 2026 | 1.00 |
| September 11, 2026 | 0.9801 |
| September 10, 2026 | 0.9762 |
| September 09, 2026 | 0.97 |
| September 08, 2026 | 1.06 |
| September 04, 2026 | 0.9601 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.00 |
| September 02, 2026 | 0.8645 |
| September 01, 2026 | 0.8254 |
| August 31, 2026 | 0.8575 |
| August 28, 2026 | 0.83 |
| August 27, 2026 | 0.7957 |
| August 26, 2026 | 0.711 |
| August 25, 2026 | 0.7999 |
| August 24, 2026 | 0.84 |
| August 21, 2026 | 0.8982 |
| August 20, 2026 | 0.8982 |
| August 19, 2026 | 0.9451 |
| August 18, 2026 | 0.8742 |
| August 17, 2026 | 0.8578 |
| August 14, 2026 | 0.9083 |
| August 13, 2026 | 0.9683 |
| August 12, 2026 | 0.9691 |
| August 11, 2026 | 0.9942 |
| August 10, 2026 | 0.959 |
| August 07, 2026 | 1.030 |
| August 06, 2026 | 1.030 |
| August 05, 2026 | 1.019 |
| August 04, 2026 | 1.08 |
| August 03, 2026 | 1.050 |
| July 31, 2026 | 1.019 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Anika Therapeutics, Inc. | 19.58 |
| Perspective Therapeutics, Inc. | 2.66 |
| MiMedx Group, Inc. | 4.67 |
| Abbott Laboratories | 223.29 |
| AngioDynamics, Inc. | 11.52 |